Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes.
Akira OnishiHideaki TsujiYudai TakaseYuto NakakuboTakeshi IwasakiTomohiro KozukiTsuneyasu YoshidaMirei ShirakashiHideo OnizawaRyosuke HiwaKoji KitagoriShuji AkizukiRan NakashimaHajime YoshifujiMasao TanakaAkio MorinobuPublished in: Rheumatology (Oxford, England) (2023)
No clear differences were identified in the use of the SLE-DAS over the SLEDAI-2K in assessing PROs in patients with SLE. The classification of disease activity based on the SLE-DAS was validated against several PROs. SLE-DAS and its categories of disease activity effectively explain some of the PROs.